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Background: The aim of this retrospective study is to compare outcomes and reconstruction 
related complications in patients receiving a composite free flap reconstruction of the 
mandible for ORN with those reconstructed for other indications. 
Patients and Methods: The records of all patients who underwent composite reconstruction 
of a mandibular defect at Aintree University Hospital, Liverpool were reviewed and analysed. 
Based on radiotherapy exposure and ORN history, the study cohort was divided into 3 











Results: Local wound healing issues were markedly more common in the ORN setting, as 
was infection and subsequent osteosynthesis plate(s) removal. Free flap survival was similar 
among all 3 case-matched groups. 
Conclusion: Advanced mandibular ORN may be safely and predictably reconstructed with 
composite free flaps, and that while the rate of local complications is greater than non-
irradiated, and non-ORN case-matched controls, the free flap survival rate compares 
favorably.  
Keywords: osteoradionecrosis; composite free flap; mandible 
 
Introduction 
Osteoradionecrosis (ORN) is exposed necrotic bone after radiotherapy in the absence of 
neoplasia. Affected patients suffer from malnutrition, opiate dependency, infection, 
disfigurement, and reduced quality of life[1].  The reported incidence of ORN ranges from 2 
to 22%, with a steady decrease in more recent published series, which converge on a rate of 6-
8% [2, 3, 4, 5, 6]. However, the incidence of head and neck cancer [7, 8] is increasing, as is 
survival and use of radiotherapy. Therefore, the at-risk population is increasing.  
 
Surgical resection and free flap reconstruction remains the mainstay for advanced ORN 
(Notani Stage III). However, vessel depletion, tissue fibrosis, and impaired wound healing 
increase the risk of late wound complications. Historically, reconstruction of irradiated tissues 
carried a higher risk of complications, including flap failure[9, 10, 11, 12]. Deutsch et al[13] 
reported that both pre- and post-operative radiotherapy is associated with an increased flap 
complication rate, and that the timing of radiation therapy did not affect the rate of 
complications. The effect of radiotherapy on vessels, and therefore microvascular anastomosis 











muscle activity have been demonstrated with scanning electron microscopy of irradiated 
recipient neck vessels[14]. Others have reported that radiotherapy does not affect the rate of 
complications associated with free flaps[15].  
 
The aim of this retrospective study is to compare outcomes (free flap survival) and 
reconstruction related complications in patients receiving a composite free flap reconstruction 
of the mandible for ORN with those reconstructed for other indications. Additionally, we will 
explore the effect of post-operative radiotherapy on the outcomes of composite reconstruction 
in the absence of ORN.  
 
Patients and Methods 
The records of all patients who underwent composite reconstruction of a mandibular defect at 
Aintree University Hospital, Liverpool, between October 1990 and November 2015 were 
reviewed. In addition to a prospectively updated computerised database[16], case notes 
including operation notes, histo-pathology reports, and radiographs were used to gather 
information. The following variables were recorded:  patient demographics, indication for 
resection, length of bone defect, pathological diagnosis and stage, flap donor site, pre- or post- 
operative radiotherapy (PORT), fixation type and length of admission. Additionally, the 
mandibular defect was classified according to Brown et al[17].  
 
Among this cohort of 471 patients, the indications for resection were as follows: Squamous 
Cell carcinoma, n=354 (75%); ORN, n=49 (10%); Ameloblastoma, n=11 (2.3%); Adenoid 
Cystic Carcinoma, n=8 (1.7%); Mucoepidermoid Carcinoma, n=7 (1.5%); Carcinoma in Ex-













For the purposes of comparison, the study cohort was divided into 3 separate case-matched 
groups, each of 49 patients.   
Group 1, Patients who had a resection and reconstruction for ORN; Group 2, Patients who 
had reconstruction following tumour resection and subsequently received PORT; Group 3, 
patients similar to group 2 but who did not receive pre- or post-operative radiotherapy.  
The patients in each group were selected as follows: Group 1 (ORN) as all patients with 
complete data, groups 2 and 3 were matched according to age, sex, length and position (class) 
of defect, donor site, as well as the era (5-year period) during which reconstruction took place.  
All patients received primary flap reconstruction, i.e. were reconstructed at the time of 
resection. 
The endpoints of interest were free flap survival, as well as development of reconstruction 
related complications.   
Complications were classified as follows:  
1. Flap failure (complete or partial) 
2. Non-union 
3. Local wound issue requiring re-admission or re-operation (bone exposure/removal, 
minor infection, and dehiscence)* 
4. Plate removal 
5. Donor site§ 
 
*The classification of local wound complications used here is as in our previous publication on mandible 
reconstruction[18].  













There were 147 patients (56 female, 91 male) in our study cohort. The mean age was 60.4 
years (range, 17 to 86 years).  Squamous cell carcinoma or other malignancies accounted for 
the vast majority of patients in groups 1 and 2, while benign conditions, including trauma, 
accounted for 22% of patients’ in group-3.  
 
Patient, defect, and donor site characteristics are described in Table 1. All complications, 
including partial and complete flap failure, are outlined in Table 2. 
The distribution of donor sites for the ORN cases is outlined in figure 2.  
 
In group-1, there were three complete flap failures. The donor sites for these cases were two 
DCIA flaps and 1 fibula flap. A Latissimus dorsi and two composite radial flaps respectively 
were used as salvage reconstructions in these cases. The precise cause of flap failure could not 
be reliably ascertained. Another patient in this group lost the skin paddle component of a 
fibula flap, and a delto-pectoral flap was used for salvage.  One patient suffered partial 
necrosis of the muscle component of a DCIA flap, which did not necessitate any additional 
salvage reconstruction.  
Local wound healing issues were markedly more common in the ORN setting, occurring in 
47% of group-1; compared to 28% is group-2 and only 8% in group-3.  
 In Group-1, infection accounted for 78% (n=18), wound dehiscence 13% (n=3), and bone 
exposure 9% (n=2). In Group-2, infection accounted for 36% (n=5), dehiscence 36% (n=5), 
and bone exposure 28% (n=4); while in Group-3 infection was 50% (n=2), dehiscence 25% 












Similarly, osteosynthesis plate(s) removal was also more common in ORN. Twenty-two 
(45%) patients in group-1 had hardware removed but only 1 patient in group-3 (no 
radiotherapy, no ORN) and, again, an intermediate number (14%) in group-2. Two patients 
(4%) in group-1 suffered a non-union, while this complication did not occur in group-3.  
Within group-1, five (10.2%) patients developed further ORN, all on the ipsilateral side. Of 
these patients, one occurred distal to the free flap in the pre-molar area, while all others 
occurred proximally (typically the mandibular angle/ascending ramus). A non-union occurred 
in 3 of 5 patients, all at the site of ORN recurrence. Further ORN in the condyle, which were 
retained where possible, occurred in only one patient. All ORN recurrences, apart from the 
condyle, occurred immediately adjacent to the free flap, and represented the resection margin. 
The patient with ORN recurrence at the condyle had a primary tonsil tumor, unlike all others, 













Our findings suggest that mandibular ORN may be predictably managed with free flap 
reconstruction, albeit with an increased complication rate. In this case-matched study, the 
overall rate of free flap survival in the ORN cohort was similar to patients who underwent 
free flap reconstruction for other indications. The partial flap failure rate, e.g. skin/muscle 
necrosis, was also similar among the 3 groups. However, the rate of local complications 
(47%) and the need for removal of hardware (45%) was significantly higher in the ORN 
cohort.  
Additionally, we found that the late recipient-site complication rate was not influenced by 
donor site choice but rather that the only significant factor influencing re-admission and late 
fixation-related complication rate was prior radiotherapy. 
 
Our study is limited by its retrospective nature. While certain data collected was retrieved 
from our prospectively completed database; some was obtained via operation and case notes, 
pathology reports, and radiographs, none of which was recorded in a standardised fashion. We 
were not, for example, able to match according to smoking status, co-morbidities, duration of 
ORN, and the size of the soft tissue component of the harvested free flap. Similarly, a 
prospective study looking at reconstruction related complications would have additionally 
looked at, among other variables, malocclusion, mid-line shift, and marginal mandibular 
nerve weakness.  
ORN cases present with fistulae, infection, fractures, through and through defects  but small 
intra-oral soft tissue volume requirements. Primary cancer resections often have substantial 
intra-oral soft tissue volume defects and less often require extra-oral skin paddles, and 
doubtless this disparity is greater in those cases that required adjuvant radiotherapy than in 











complications, but often inadequately measured in surgical records. This is challenging to do 
quantitatively and is a learning point for future studies. 
However, we have closely matched all ORN patients to similar (non-ORN) cases based on 
age, class of defect, donor site, length of defect, and the era in which the reconstruction was 
performed. It is however likely that there has been an under-reporting of complications, 
particularly minor or late. Nevertheless, the data on flap failure, we believe, is accurate. In 
addition, we do not comment on the total received dose of radiotherapy, or the extent of 
fields, as this information was not available to us for all included cases. However, this is 
likely more relevant to the risk of ORN development as opposed to free flap survival.  
 
The risk of ORN is higher in the posterior mandible and if > 60 Gy has been received[2, 19, 
20]. In Group-1 (ORN), Class I defects predominate reflecting the commonest site of 
incidence of ORN. Previous studies have shown an increased frequency of ORN in oral cavity 
tumours, relative to other sites[21].  
Class I defects involve the lateral mandible, excluding the canine and condyle. 
Notwithstanding the importance of radiation dose, it is possible that anatomical variation, 
including muscle insertions and blood supply influence the propensity for ORN at this site. 
For example, the anterior mandible may benefit from insertion of both the mentalis and genio-
hyoid muscles. Similarly, the ramus may benefit from insertion of the medial pterygoid and 
masseter muscles.  
 
Our data (Figure. 1) shows an increase in composite flap reconstruction for ORN, nearly 
doubling every 5 years.  Anecdotally this trend has continued since 2015. Although we cannot 
extrapolate on the rates of ORN itself, as our study does not account for those patients 











this prescription), or those awaiting surgery, it is clear that the number of cases requiring 
definitive ablative and reconstructive surgery is increasing.  
 
 
The other notable trend has been for an increased reliance on the fibula donor site for ORN 
cases (figure. 2). While not presented here; since 2015, we have successfully implemented the 
tip of scapula in highly selected cases, particularly where peroneal vessels are unsuitable and 
contralateral neck vascular access is mandated[22].  
 
Lee et al[23], in a systematic review of free flap reconstruction for the management of ORN 
reported a flap failure rate of 9.8% (range, 9-16%). Our rate of 6% compares favorably to this. 
In addition, it compares favorably to our control groups (groups 2, and 3) with flap failure 
rates of 8% and 10% respectively. These results support our hypothesis that composite free 
flap reconstruction in ORN cases is non-inferior to non-ORN and non-irradiated controls.  
While our study was not adequately powered to draw statistical significance, there appeared 
to be no correlation between donor site and rate of failure. 
 
The healing of irradiated tissue is compromised, and this may manifest as infection, local 
wound breakdown, fistula formation, and/or hardware exposure. In the aforementioned 
systematic review[23], an overall local wound healing complication rate of 42% was reported.  
In our study, the incidence of local wound issues in group-1 was similar, at 47%. These 
results suggest that post-operative radiotherapy does not affect free flap viability, but rather 
may increase the rate of local wound and hardware complications.  Pohlenz et al[24], in a 
review of 202 microvascular reconstructions, found that pre-operative radiation therapy was 











al[25] also found a statistically significant association between prior radiotherapy and 
recipient site complications. However, it must be considered that ORN itself is a risk factor 
for wound complications (as opposed to free flap survival). In our study, the rate of local 
wound complications for ORN is 47% versus 28% for those who had radiotherapy but no 
ORN. Similarly, Suh et al[26], in 2004 found a significantly increased rate of local 
complications in ORN cases, when compared to non-ORN but irradiated patients.  
 
In our practice, resection margins are based both on clinical findings at operation and pre-
operative radiographic evidence for osteonecrosis. Despite aggressive resection of obviously 
non-viable bone, 10% (n=5) of our patients developed further ORN, of which only one 
occurred at the condyle. Suh et al[27] reported a 25% recurrence rate in a review of 40 
patients who had segmental resection and reconstruction for the management of ORN. 
Interestingly, 70% (n=7) of their recurrences developed at the condyle or subcondyle. The 
majority of their patients had oropharynx site primary tumours and it is therefore conceivable 
that the difference in both the rate and location of recurrence may be related to the area 
irradiated as well as the dose delivered. They further postulate that the recurrence of ORN 
following an apparently adequate resection may be related to a poor understanding of the 
pathophysiology of ORN, and that the presence or absence of bleeding may be insufficient to 
guide the extent of resection. Changes in bone homeostasis and metabolism may account for 
an ongoing disease process and therefore recurrence. This is in keeping with the fact that 
ORN can occur many years after radiotherapy, and that a reduced capacity to heal may be 
permanent[28].  It should also be noted that surgical trauma in the form of muscle stripping 
and placement of fixation screws, may render retained bone more susceptible to development 
of further ORN. Koka et al[29] reported a recurrence rate of 14.5% within 1 to 41 months 











The incidence of ORN5, at 6%, is low. However, the incidence of head and neck malignancy 
and use of radiation therapy is increasing. Human papillomavirus (HPV) has a significant role 
in the increasing incidence in the oropharynx, and with near universal use of radiotherapy in 
its management of this disease group, younger age and better survival, the ‘at-risk’ population 
for ORN is increasing. Radiation induced vascular atrophy has led to concerns about free flap 
survival in previously irradiated tissue. Our findings suggest that advanced mandibular ORN 
may be safely and predictably reconstructed with composite free flaps, and that while the rate 
of local complications is greater than non-irradiated, and non-ORN case-matched controls, the 
free flap survival rate compares favorably.  
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Figures for ORN manuscript 
 
 




Figure 2. Donor sites for ORN reconstructions 
 
Tables for ORN Manuscript 
 
 Group 1 (O RN) Group 2 (Rad, No 
O RN) 
Group 3 (No Rad, No 
O RN) 
Number of patients 
 
49 (12 F, 37M) 49 (27F, 22M) 49 (17F, 32M) 
Age (years) Mean 58.1 (range, 44-
74) 
 
Mean 63.9 (range, 43 -
84) 
Mean 59.3 (range, 17-
86) 
Classification  
 Class I 
 Class II 
 Class III 




7   (14%) 
3   (6%) 




6   (12%) 




7   (14%) 
0 














































 Scapula 2  (4%) 2  (4%) 2   (4%) 
 
Length of defect (mm) 
 
Mean 75.7 (range, 27-
125) 
Mean 79.9 (range, 40-
130) 
Mean 72.4 (range, 43-
120) 
 
Length of stay (days) Mean 22 (range, 6-
156) 
Mean 25.6 (range, 11-
148) 
 
Mean 19.3 (range, 7-
60) 





















Osteotomy in osseous component 
of Free flap (% ) 
 
32 (66%) 28 (57%) 28 (58%) 
Method of fixation (% ) 






















Complication Group 1, (ORN) 
Number (% ) 
Group 2, (RT, no 
ORN) Number  (% ) 
Group 3, (no RT) 
Number (% ) 
Flap failure (complete) 3 (6) 4 (8) 5 (10) 
Flap failure (partial) 1 (2) 2 (4) 1 (2) 
Non-union 2 (4) 1 (2) 0 
Reconstructed site 
complications*  
23 (47) 14 (28) 4 (8) 
Donor site: minor  4 (8) 2(4) 1 (2) 
Osteosynthesis plate 
removal 
22 (45) 7 (14) 1 (2) 
Table 2. Complications. *Bone exposure/removal, minor infection, and soft-tissue dehiscence.  
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